Assessing the role of Chemokine (C-C motif) ligand 14 in AKI: a European consensus meeting

CONCLUSION: Real world urinary CCL14 use appears to provide improved care options to patients at risk for persistent severe AKI. Experts believe there is a role for CCL14 in AKI management and it may potentially reduce AKI-disease burden. There is, however, an urgent need for evidence on treatment decisions and adjustments based on CCL14 results.PMID:38666354 | DOI:10.1080/0886022X.2024.2345747

Source: Renal Failure - April 26, 2024 Category: Urology & Nephrology Authors: Jay L Koyner Christian Arndt Jaume Baldira Martinez de Irujo S ílvia Coelho Manuel Garcia-Montesinos de la Pe ña Luca di Girolamo Michael Joannidis Pablo Jorge-Monjas Christian Koch Steven Lobaz Alain Meyer Marlies Ostermann Nicoletta Pertica John R Pro Source Type: research